You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 4, April 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE SIXTH ANNUAL SURGICAL SYMPOSIUM OF THE ASSOCIATION OF VETERANS ADMINISTRATION SURGEONS, ATLANTA, MAY 13-15, 1982
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hemodynamic Effects of Vasopressin

Can Large Doses Be Safely Given?

Harold V. Gaskill, III, MD; Kenneth R. Sirinek, MD; Barry A. Levine, MD

Arch Surg. 1983;118(4):434-437.


Abstract

• We evaluated the effects of intravenous (IV) vasopressin on central hemodynamics, as well as myocardial and gastrointestinal (GI) blood flow, to delineate an optimal dosage balanced to yield maximum reduction of GI blood flow with minimal adverse cardiac effects. Eight miniature swine were anesthetized, ventilated, catheterized, and infused with vasopressin for three consecutive 30-minute periods at logarithmically increasing doses (0.001, 0.01, and 0.1 units/kg/min). We determined cardiac output, systemic arterial pressure, and microsphere tissue blood flow after each infusion. We found that IV vasopressin (0.001 units/kg/min) produced substantial reductions in blood flow to the GI tract and heart, and reduced the cardiac index (3.0±0.4 to 2.1 ±0.3 L/sq m/min). Increased doses of vasopressin (x10 and x 100) decreased gastric mucosal blood flow even more, with minimal adverse effects on cardiac output and myocardial blood flow.

(Arch Surg 1983;118:434-437)



Author Affiliations

From the Surgical Service, Audie L. Murphy Memorial Veteran's Hospital (Drs Levine and Gaskill), and the Department of Surgery, University of Texas Health Science Center (Dr Sirinek), San Antonio.


Footnotes

Accepted for publication Oct 12, 1982.

Read before the Sixth Annual Surgical Symposium of the Association of Veterans Administration Surgeons, Atlanta, May 14, 1982.

Reprint requests to Department of Surgery, University of Texas Health Science Center, 7703 Floyd Curl Dr, San Antonio, TX 78284 (Dr Levine).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-Dose Vasopressin for Acute Variceal Hemorrhage: Clinical Advantages Without Adverse Effects
Sirinek and Levine
Arch Surg 1988;123:876-880.
ABSTRACT  

Vasopressin Therapy for Upper Gastrointestinal Tract Hemorrhage: Has Its Efficacy Been Proven?
Hussey
Arch Intern Med 1985;145:1263-1267.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.